首页> 外文期刊>Journal of Natural Science Biology and Medicine >Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
【24h】

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis

机译:0.03%他克莫司眼药膏局部应用在过敏性结膜炎治疗中的功效

获取原文
           

摘要

Background:Allergic conjunctivitis is commonly observed eye diseases in Sikkim, India due to the abundance of seasonal pollens, environmental pollutants, and house dust. We evaluated the efficacy of topical 0.03% tacrolimus eye ointment in the management of simple allergic conjunctivitis.Materials and Methods:A prospective observational study was designed consisting of 41 patients with refractory simple allergic conjunctivitis, whose condition responded very poorly to conventional anti-allergic eye drops (azelastine, olopatadine, chlorpheniramine maleate, sodium chromoglycate). Simple allergic conjunctivitis cases were diagnosed and followed up evaluating both subjective and objective findings (itching, photophobia, tearing, chemosis, conjunctival congestion, tarsal papilla, and eyelid edema). Existing ocular treatment was discontinued at enrolment and 0.03% tacrolimus ointment was applied into the conjunctival sac of the affected eyes twice daily for 4 weeks followed by a 2 weeks washout period. Patients were followed up at the end of 1st week, 4th week, and at 7th week (2 weeks washout period).Results:Symptoms of simple allergic conjunctivitis (itching, tearing and photophobia) were significantly reduced at the end of 1st week. Signs such as conjunctival chemosis, congestion, tarsal papillae, and eyelid edema were effectively treated in all cases at the end of 1st week. At the end of 4th week, all cases were fully cured and none of the patient had any recurrences up to 7th week. Mean score at 1st day (9.6 ± 3.27) was significantly (P < 0.0001) reduced by 7th day (1.35 ± 1.19) of treatment.Conclusion:Topical application of tacrolimus ointment is an excellent alternative to anti-allergic and steroids eye drops for the treatment of simple allergic conjunctivitis as it significantly reduces recurrences.
机译:背景:由于大量的季节性花粉,环境污染物和房屋灰尘,过敏性结膜炎是印度锡金常见的眼病。我们评估了局部使用0.03%他克莫司眼药膏治疗单纯性过敏性结膜炎的疗效。材料与方法:前瞻性观察性研究设计了41例难治性单纯性过敏性结膜炎患者,其对常规抗过敏性眼病的反应非常差滴(氮卓斯汀,奥洛他定,马来酸氯苯那敏,色糖酸钠)。诊断出简单的过敏性结膜炎病例,并进行随访,评估主观和客观发现(瘙痒,畏光,流泪,化学反应,结膜充血,乳头和眼睑水肿)。入组时停止现有的眼部治疗,并将0.03%的他克莫司软膏每天两次施用于患眼的结膜囊中,持续4周,然后进行2周的冲洗期。在第1周,第4周和第7周(冲洗期为2周)时对患者进行随访。结果:在第1周末,单纯过敏性结膜炎(瘙痒,流泪和畏光)的症状明显减轻。在第一周结束时,所有病例均有效治疗了结膜水肿,充血,睑板乳头和眼睑浮肿等体征。在第4周结束时,所有病例均已完全治愈,并且直到第7周为止,没有患者复发。治疗第1天的平均评分(9.6±3.27)显着(P <0.0001),而治疗第7天的平均评分(1.35±1.19)降低。结论:他克莫司软膏的局部应用是抗过敏药和类固醇滴眼剂的绝佳替代品。治疗简单的过敏性结膜炎,因为它可以显着降低复发率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号